T. Rowe Price (FTI) discloses 9% passive stake in TechnipFMC in 13G/A

Rhea-AI Filing Summary

T. Rowe Price Associates, Inc. filed an amended Schedule 13G reporting beneficial ownership of 36,302,889 shares of TechnipFMC plc common stock, representing 9.0% of the outstanding class as of the event date. The firm reports sole voting power over 35,744,259 shares and sole dispositive power over 36,302,793 shares, with no shared voting or dispositive power. T. Rowe Price states these securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of TechnipFMC.

Insights

Equity ownership and governance analyst

T. Rowe Price reports a 9% passive stake in TechnipFMC.

T. Rowe Price Associates, Inc. discloses beneficial ownership of 36,302,889 TechnipFMC shares, or 9.0% of the common stock. The firm has sole voting and dispositive power over essentially all of these shares, indicating concentrated institutional influence on shareholder votes.

The filing is made on a Schedule 13G, which is reserved for holders certifying a passive, non-control intent. T. Rowe Price affirms the position is held in the ordinary course of business and not to change or influence control of TechnipFMC.

For investors, this highlights a significant long-only institutional holder whose voting decisions can matter in director elections and key proposals. Future ownership updates in later filings will show whether this passive stake grows, shrinks, or remains stable over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 10:26 AM Learn about SEC filing dates

FAQ

How many TechnipFMC (FTI) shares does T. Rowe Price report owning?

T. Rowe Price Associates, Inc. reports beneficial ownership of 36,302,889 shares of TechnipFMC common stock. This position gives the firm a 9.0% stake in the company’s outstanding common stock as disclosed in the amended Schedule 13G filing.

What percentage of TechnipFMC (FTI) does T. Rowe Price’s 13G/A represent?

The filing shows T. Rowe Price beneficially owning 9.0% of TechnipFMC’s common stock. This percentage is based on 36,302,889 shares reported as beneficially owned, making the firm a significant institutional shareholder in the company.

Does T. Rowe Price have voting control over its TechnipFMC (FTI) shares?

T. Rowe Price reports sole voting power over 35,744,259 shares of TechnipFMC and no shared voting power. It also reports sole dispositive power over 36,302,793 shares, indicating it alone decides how to vote and dispose of these shares.

Is T. Rowe Price’s TechnipFMC (FTI) stake considered passive or activist?

The stake is described as passive. T. Rowe Price certifies the securities were acquired and are held in the ordinary course of business and not for changing or influencing control of TechnipFMC, consistent with a Schedule 13G filing.

What type of filing did T. Rowe Price submit for TechnipFMC (FTI)?

T. Rowe Price submitted an amended Schedule 13G/A relating to TechnipFMC common stock. This form is used by investors who exceed 5% ownership but certify that their holdings are not for the purpose of influencing or changing control.

When was the ownership event for T. Rowe Price’s TechnipFMC (FTI) stake dated?

The date of the event requiring the Schedule 13G/A filing is listed as December 31, 2025. That date anchors when T. Rowe Price’s beneficial ownership level in TechnipFMC’s common stock met the disclosure threshold reflected in this amendment.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

TECHNIPFMC PLC

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

G87110105

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G87110105

1

Names of Reporting Persons

T. Rowe Price Associates, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 35,744,259.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 36,302,793.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

36,302,889.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.0 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: TECHNIPFMC PLC
(b)	Address of issuer's principal executive offices: HADRIAN HOUSE, WINCOMBLEE ROAD, NEWCASTLE UPON TYNE, X0, NE63PL
Item 2.
(a)	Name of person filing: T. Rowe Price Associates, Inc.
(b)	Address or principal business office or, if none, residence: 1307 Point Street, Baltimore, MD 21231
(c)	Citizenship: Maryland
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: G87110105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 36302889
(b)	Percent of class: 9.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 35744259
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 36302793
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

T. Rowe Price Associates, Inc.

Signature:	Ellen York
Name/Title:	Vice President
Date:	02/17/2026